TheraVasc Garners $172,501 New Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    10000 Cedar Ave Cleveland, OH 44106
  • Company Description
    TheraVasc, Inc. is a privately-held biotechnology company with offices in Louisiana, focused on the development of novel vascular therapies with decreased risks through the repositioning of drugs with known safety profiles. The Company’s first program is ready to enter clinical trials for the treatment of peripheral artery disease (PAD).
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
  • M&A Terms
  • Venture Investor

Trending on Xconomy